JP2018537949A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018537949A5 JP2018537949A5 JP2018513634A JP2018513634A JP2018537949A5 JP 2018537949 A5 JP2018537949 A5 JP 2018537949A5 JP 2018513634 A JP2018513634 A JP 2018513634A JP 2018513634 A JP2018513634 A JP 2018513634A JP 2018537949 A5 JP2018537949 A5 JP 2018537949A5
- Authority
- JP
- Japan
- Prior art keywords
- dendritic cell
- tnfα
- activated
- cells
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021186960A JP2022028818A (ja) | 2015-09-15 | 2021-11-17 | 進行したがんを有する被験体のための活性化樹状細胞組成物および免疫療法処置に関する方法 |
| JP2023200819A JP2024019229A (ja) | 2015-09-15 | 2023-11-28 | 進行したがんを有する被験体のための活性化樹状細胞組成物および免疫療法処置に関する方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562219058P | 2015-09-15 | 2015-09-15 | |
| US62/219,058 | 2015-09-15 | ||
| PCT/US2016/051781 WO2017048875A1 (en) | 2015-09-15 | 2016-09-14 | Methods relating to activated dendritic cell compositions and immunotherapeutic treatments for subjects with advanced cancers |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021186960A Division JP2022028818A (ja) | 2015-09-15 | 2021-11-17 | 進行したがんを有する被験体のための活性化樹状細胞組成物および免疫療法処置に関する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018537949A JP2018537949A (ja) | 2018-12-27 |
| JP2018537949A5 true JP2018537949A5 (https=) | 2019-10-31 |
| JP6980650B2 JP6980650B2 (ja) | 2021-12-15 |
Family
ID=58289879
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018513634A Active JP6980650B2 (ja) | 2015-09-15 | 2016-09-14 | 進行したがんを有する被験体のための活性化樹状細胞組成物および免疫療法処置に関する方法 |
| JP2021186960A Withdrawn JP2022028818A (ja) | 2015-09-15 | 2021-11-17 | 進行したがんを有する被験体のための活性化樹状細胞組成物および免疫療法処置に関する方法 |
| JP2023200819A Pending JP2024019229A (ja) | 2015-09-15 | 2023-11-28 | 進行したがんを有する被験体のための活性化樹状細胞組成物および免疫療法処置に関する方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021186960A Withdrawn JP2022028818A (ja) | 2015-09-15 | 2021-11-17 | 進行したがんを有する被験体のための活性化樹状細胞組成物および免疫療法処置に関する方法 |
| JP2023200819A Pending JP2024019229A (ja) | 2015-09-15 | 2023-11-28 | 進行したがんを有する被験体のための活性化樹状細胞組成物および免疫療法処置に関する方法 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20190046568A1 (https=) |
| EP (2) | EP3971285A3 (https=) |
| JP (3) | JP6980650B2 (https=) |
| KR (1) | KR20180044430A (https=) |
| CN (2) | CN116413420A (https=) |
| AU (2) | AU2016323066B2 (https=) |
| BR (1) | BR112018005180B1 (https=) |
| CA (1) | CA2998614A1 (https=) |
| DK (1) | DK3350318T3 (https=) |
| ES (1) | ES2923769T3 (https=) |
| HU (1) | HUE059560T2 (https=) |
| IL (3) | IL286225B2 (https=) |
| MX (2) | MX393996B (https=) |
| PL (1) | PL3350318T3 (https=) |
| RU (1) | RU2749610C2 (https=) |
| WO (1) | WO2017048875A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20190076473A1 (en) * | 2017-09-14 | 2019-03-14 | Cellular Approaches, Inc. | Autologous and allogenic macrophages and monocytes for use in therapeutic methods |
| CN110106145B (zh) * | 2019-06-12 | 2021-02-12 | 蓝莲(杭州)生物科技有限公司 | 一种未成熟树突状细胞培养液及其未成熟树突状细胞的制备方法 |
| AU2020363707A1 (en) * | 2019-10-07 | 2022-04-28 | Northwest Biotherapeutics, Inc. | In vitro methods and compositions for enhancing the activation of dendritic cells and t cells, and for inducing a th-1 immune response |
| CN119286782B (zh) * | 2024-12-11 | 2025-04-04 | 上海赛笠百傲生物医药有限公司 | 一种高效诱导外周血来源单核细胞至不成熟树突状细胞的方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT633929E (pt) | 1992-04-01 | 2004-07-30 | Merix Bioscience Inc | Metodo para proliferacao (in vitro) de precursores de celulas dentifricas e sua utilizacao para produzir imunogenios |
| US7659119B2 (en) | 1996-02-12 | 2010-02-09 | Argos Therapeutics, Inc. | Method and compositions for obtaining mature dendritic cells |
| US6558951B1 (en) * | 1999-02-11 | 2003-05-06 | 3M Innovative Properties Company | Maturation of dendritic cells with immune response modifying compounds |
| US20020094545A1 (en) | 2000-11-30 | 2002-07-18 | Harris Paul E. | Growth of human dendritic cells for cancer immunotherapy in closed system using microcarrier beads |
| AU2002326463A1 (en) | 2001-07-25 | 2003-02-17 | Northwest Biotherapeutics, Inc. | Methods and apparatus for enrichment and culture of monocytic dendritic cell precursors |
| WO2004000444A1 (en) | 2002-06-19 | 2003-12-31 | Northwest Biotherapeutics, Inc. | Tangential flow filtration devices and methods for leukocyte enrichment |
| WO2004039968A1 (ja) * | 2002-10-30 | 2004-05-13 | Japan Science And Technology Agency | 骨髄由来の不死化樹状細胞株 |
| ES2354944T3 (es) * | 2002-12-06 | 2011-03-21 | Northwest Biotherapeutics, Inc. | Administración de células dendríticas maduradas parcialmente in vitro para el tratamiento de tumores. |
| ES2321939T3 (es) * | 2003-02-27 | 2009-06-15 | Northwest Biotherapeutics, Inc. | Generacion de celulas dendriticas a partir de celulas precursoras dendriticas monociticas con gm-csf en ausencia de citoquinas adicionales. |
| US20060257359A1 (en) * | 2005-02-28 | 2006-11-16 | Cedric Francois | Modifying macrophage phenotype for treatment of disease |
| KR20080109717A (ko) * | 2005-12-08 | 2008-12-17 | 노쓰웨스트 바이오써라퓨틱스, 인크. | 미성숙 단핵구성 수지상 세포의 활성화를 유도하기 위한조성물 및 방법 |
| JP5382529B2 (ja) * | 2007-09-10 | 2014-01-08 | 独立行政法人理化学研究所 | ヒト樹状細胞の評価方法およびヒト細胞免疫療法剤 |
| EP2072617A1 (en) * | 2007-12-12 | 2009-06-24 | Trimed Biotech GmbH | Method for producing dendritic cells |
| MX2011012147A (es) * | 2009-05-15 | 2012-06-19 | Irx Therapeutics Inc | Inmunoterapia de vacuna. |
| CN103638517A (zh) * | 2013-12-04 | 2014-03-19 | 深圳市合一康生物科技有限公司 | 人树突状细胞疫苗制备的专用试剂盒 |
| WO2016048872A1 (en) * | 2014-09-23 | 2016-03-31 | Neostem Oncology, Llc | Compositions, methods and kits used to determine potency of dendritic cells in cancer immunitherpay |
-
2016
- 2016-09-14 JP JP2018513634A patent/JP6980650B2/ja active Active
- 2016-09-14 DK DK16847253.8T patent/DK3350318T3/da active
- 2016-09-14 IL IL286225A patent/IL286225B2/en unknown
- 2016-09-14 EP EP21189488.6A patent/EP3971285A3/en active Pending
- 2016-09-14 RU RU2018113435A patent/RU2749610C2/ru active
- 2016-09-14 IL IL313283A patent/IL313283B2/en unknown
- 2016-09-14 MX MX2018003197A patent/MX393996B/es unknown
- 2016-09-14 ES ES16847253T patent/ES2923769T3/es active Active
- 2016-09-14 CA CA2998614A patent/CA2998614A1/en active Pending
- 2016-09-14 US US15/759,699 patent/US20190046568A1/en active Pending
- 2016-09-14 KR KR1020187010610A patent/KR20180044430A/ko active Pending
- 2016-09-14 AU AU2016323066A patent/AU2016323066B2/en active Active
- 2016-09-14 CN CN202211533672.XA patent/CN116413420A/zh active Pending
- 2016-09-14 BR BR112018005180-2A patent/BR112018005180B1/pt active IP Right Grant
- 2016-09-14 EP EP16847253.8A patent/EP3350318B1/en active Active
- 2016-09-14 CN CN201680066721.XA patent/CN108291204A/zh active Pending
- 2016-09-14 WO PCT/US2016/051781 patent/WO2017048875A1/en not_active Ceased
- 2016-09-14 HU HUE16847253A patent/HUE059560T2/hu unknown
- 2016-09-14 PL PL16847253.8T patent/PL3350318T3/pl unknown
-
2018
- 2018-03-13 IL IL258071A patent/IL258071B/en unknown
- 2018-03-14 MX MX2022008806A patent/MX2022008806A/es unknown
-
2021
- 2021-11-17 JP JP2021186960A patent/JP2022028818A/ja not_active Withdrawn
-
2023
- 2023-07-27 AU AU2023208190A patent/AU2023208190B2/en active Active
- 2023-11-28 JP JP2023200819A patent/JP2024019229A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Weiner | The immunobiology and clinical potential of immunostimulatory CpG oligodeoxynucleotides | |
| MacLeod et al. | Memory CD4 T cells: generation, reactivation and re‐assignment | |
| Araki et al. | The role of mTOR in memory CD8+ T‐cell differentiation | |
| Brunner et al. | Enhanced dendritic cell maturation by TNF-α or cytidine-phosphate-guanosine DNA drives T cell activation in vitro and therapeutic anti-tumor immune responses in vivo | |
| Santini et al. | The natural alliance between type I interferon and dendritic cells and its role in linking innate and adaptive immunity | |
| JP5730577B2 (ja) | 樹状細胞の作製方法 | |
| RU2005121256A (ru) | Введение дендритных клеток, подвергнутых частичному созреванию in vitro, для лечения опухолей | |
| Jelley‐Gibbs et al. | Influencing the fates of CD4 T cells on the path to memory: lessons from influenza | |
| EP1153122A2 (en) | Maturation of dendritic cells with immune response modifying compounds | |
| JP2016185956A (ja) | 寛容原性療法のための細胞のプログラミングの方法 | |
| Naoe et al. | Bacillus Calmette‐Guérin‐pulsed dendritic cells stimulate natural killer T cells and γδT cells | |
| JP2008000001A (ja) | 免疫刺激オリゴヌクレオチドおよびその医薬用途 | |
| JP2018537949A5 (https=) | ||
| McAleer et al. | Educating CD4 T cells with vaccine adjuvants: lessons from lipopolysaccharide | |
| JP2018523996A5 (https=) | ||
| AU2023208190B2 (en) | Methods relating to activated dendritic cell compositions and immunotherapeutic treatments for subjects with advanced cancers | |
| Choi et al. | The function of memory CD8+ T cells in immunotherapy for human diseases | |
| RU2018103235A (ru) | Оптимально активированные дендритные клетки, индуцирующие улучшенный или повышенный противоопухолевый иммунный ответ | |
| Moll | The role of dendritic cells at the early stages of Leishmania infection | |
| Schattenberg et al. | Response of human monocyte‐derived dendritic cells to immunostimulatory DNA | |
| Daudelin et al. | IL‐6 production by dendritic cells is dispensable for CD8+ memory T‐cell generation | |
| KR20220098351A (ko) | 수지상 세포 및 T 세포의 활성화를 증진시키고 Th-1 면역 반응을 유도하기 위한 시험관내 방법 및 조성물 | |
| EP1793678A1 (en) | Dendritic cell tumor injection (dcti) therapy | |
| JP5010280B2 (ja) | ヒトリンパ球由来のワクチンアジュバント | |
| Steinman et al. | Dendritic cells: important adjuvants during DNA vaccination |